What top creators are saying about Metformin(METF)

A medication for type 2 diabetes often used off-label for its potential anti-aging properties.

3 AI-extracted insights from 3 sources — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Not enough scored insights about Metformin in the last 30 days yet.

Top creators covering Metformin (METF)

The 3 sources with the most insights about Metformin on Kazuha.

Latest insights about Metformin (METF)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Monday, April 27, 2026

Bullish

Used as a benchmark for affordability in longevity treatments; research suggests it mimics calorie restriction and improves healthspan.

Very Bullish
Target: Mass market accessibility

Cited as a low-cost model for future longevity pills; used for glucose management which is the top correlate with heart disease.

Wednesday, March 25, 2026

Bullish

Included in the hierarchy of longevity interventions as a foundational pharmacological therapy.

Discussed alongside Metformin (METF)

Other assets that creators frequently mention in the same content as Metformin.

Frequently asked

Which podcasters and creators cover Metformin (METF) the most?

The most active sources covering Metformin (METF) on Kazuha are @peterdiamandis, All-In Podcast, LLC, PHD Ventures. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Metformin (METF) are on Kazuha?

Kazuha has indexed 3 AI-extracted insights about Metformin (METF) from 3 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Metformin (METF)?

Creators covering Metformin (METF) most frequently also discuss PRIVATE, RESV, BERB, NATTO, NMN. See the "Discussed alongside" section above for full asset pages.